MétaCan
Menu
Back to cohort

Cardiomyocyte Specific Knock‐out of Erythropoietin Has Adaptive Non‐Erythropoietic Effects on Cardiac Function: A Novel Cardiac Myokine

2020· article· en· W3016283166 on OpenAlexaffabout
Razan Alshamali, Brittany A. Edgett, Nadya Romanova, Laura Farquharson, Iryna Savinova, Jade P. Marrow, Melissa A. Allwood, Keith R. Brunt, Jeremy A. Simpson

Bibliographic record

VenueThe FASEB Journal · 2020
Typearticle
Languageen
FieldMedicine
TopicErythropoietin and Anemia Treatment
Canadian institutionsDalhousie UniversityUniversity of Guelph
Fundersnot available
KeywordsErythropoietinInternal medicineEndocrinologyMedicineCardiac function curveErythropoiesisContractilityAnemiaHeart failure

Abstract

fetched live from OpenAlex

Introduction Erythropoietin (EPO), in response to hypoxia, is produced by the kidney, which stimulates erythropoiesis in the bone marrow. While the kidney is regarded as the primary source of EPO, mainly in vitro expression has been shown from cells or tissues of the brain, liver, and reproductive organs. However, whether these organs are an endogenous extra‐renal source and their physiological significance is unknown. Interestingly, recombinant human EPO (rhEPO) confers cardiac cytoprotection and increases contractility. Albeit, this occurs using supra‐physiological doses of rhEPO. Whether the kidney is responsible for these effects remains to be elucidated. Therefore, the primary objective of this research is to investigate the physiological relevance of endogenous cardiomyocyte EPO production. We hypothesized that: 1) adult cardiomyoctes are a source of EPO production and 2) the loss of cardiomyocyte EPO expression leads to a decrease in contractility and an increase in susceptibility to ischemia‐reperfusion injury. Methods Cardiomyocyte‐specific deletion of EPO (EPO fl/fl‐CM ) was obtained by injecting 8‐week old α‐MHC‐MerCreMer +/− : EPO fl/fl male mice with 20 mg/kg tamoxifen daily for 5 days. Left ventricular (LV) EPO expression was determined using qPCR analysis. Cardiac structure and function were assessed by echocardiography, invasive hemodynamics and the Langendorff, respectively. Hematocrit was measured from blood collected via saphenous vein. Data was obtained 8‐weeks post‐tamoxifen. Results Paradoxically, EPO fl/fl‐CM mice exhibited a dramatic increase in whole heart EPO expression. Further, cardiac‐derived EPO confers inotropic, lusitropic and hypertrophic effects. Furthermore, in response to ischemia‐reperfusion injury, EPO fl/fl‐CM mice show profound cytoprotection. Importantly, we show that endogenous cardiac‐derived EPO is capable of improving cardiac function without affecting whole body Hct levels. Conclusion The knock‐out of EPO from the cardiomyocyte leads to a reciprocal increase in LV EPO expression, whereby an alternate cell in the heart is over‐compensating for the loss of cardiomyocyte‐derived EPO. This study furthers our fundamental understanding of EPO biology and establishes it as a novel cardiac myokine, capable of increasing cardiac function and driving hypertrophy. Support or Funding Information Heart and Stroke Foundation Canadian Institutes of Health Research

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.035
GPT teacher head0.247
Teacher spread0.212 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2020
Admission routes2
Has abstractyes

Explore more

Same venueThe FASEB JournalSame topicErythropoietin and Anemia TreatmentFrench-language works237,207